Arsenic Trioxide Injection shortage
To Be Discontinued 2 presentations · 2 manufacturers · first FDA posting Feb 24, 2026 · last update Sep 21, 2026
Manufacturers: Fresenius Kabi USA, LLC, Ingenus Pharmaceuticals LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Sep 21, 2026 Updated Sep 21, 2026 Discontinued Sep 21, 2026 |
| Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10) | Ingenus Pharmaceuticals LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Feb 24, 2026 Updated Feb 24, 2026 Discontinued Feb 24, 2026 |